Lazard Capital Boosts Target on Affymax (AFFY) to $20 Ahead of Likely FDA Approval
Go back to Lazard Capital Boosts Target on Affymax (AFFY) to $20 Ahead of Likely FDA Approval| Affymax, Inc. (AMEX: AFFY) | Delayed: 0.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $0.11 | |||
| Open | $0.00 | 52 Week Low | $0.05 | |||
| Day High | $0.00 | P/E | 0.00 | |||
| Day Low | $0.00 | EPS | $-4.15 | |||
| Volume | 327 | |||||
